This study unveiled molecular mechanism of miR-135b-5p/KLF4/GPRC5A axis in human pancreatic cancer cells and demonstrated the probability of miR-135b-5p as a new therapeutic target. The gene discussed is GPRC5A; the disease is familial pancreatic carcinoma.